Patents Assigned to CILBIOTECH S.A.
  • Patent number: 9670504
    Abstract: A transgene for endowing human quiescent cells from primary cultures with exogenously inducible telomere length homeostasis and cell cycle traverse is described. The transgene includes at least three promoter sequences; a G1-specific RNA interference sequence which is operably linked downstream of a first promoter sequence; a telomere length maintenance gene sequence which is operably linked downstream to a second promoter sequence; a Scaffold/Matrix attachment region (S/MAR) element positioned downstream in frame with said telomere length maintenance gene sequence and an exogenously-inducible transcriptional regulation system. The transgene is useful to immortalize human quiescent cells from primary cultures.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: June 6, 2017
    Assignee: CILBIOTECH S.A.
    Inventor: Alain Miller
  • Publication number: 20140199766
    Abstract: A transgene for endowing human quiescent cells from primary cultures with exogenously inducible telomere length homeostasis and cell cycle traverse is described. The transgene includes at least three promoter sequences; a G1-specific RNA interference sequence which is operably linked downstream of a first promoter sequence; a telomere length maintenance gene sequence which is operably linked downstream to a second promoter sequence; a Scaffold/Matrix attachment region (S/MAR) element positioned downstream in frame with said telomere length maintenance gene sequence and an exogenously-inducible transcriptional regulation system. The transgene is useful to immortalize human quiescent cells from primary cultures.
    Type: Application
    Filed: July 6, 2012
    Publication date: July 17, 2014
    Applicant: CILBIOTECH S.A.
    Inventor: Alain Miller